Di Cesare E, Previti M, Ingemi M C, Bagnato G F, Cucinotta D
Department of Internal Medicine, University of Messina, Italy.
Clin Exp Immunol. 1994 Feb;95(2):283-6. doi: 10.1111/j.1365-2249.1994.tb06524.x.
In type 1 (insulin-dependent) diabetes mellitus (IDDM) CD8+ T cells represent the majority of lymphocytes which infiltrate the pancreatic islets during beta cell destruction. Soluble CD8 antigen (sCD8) has been shown to correlate with CD8 cell subset activation. In this study we measured by ELISA sCD8 levels in sera from: 33 newly diagnosed IDDM patients; 29 type 1 diabetics with duration of disease more than 1 year; 37 healthy siblings of IDDM patients; 19 healthy controls. Sera from both groups of IDDM patients and from healthy siblings exhibited soluble CD8 mean levels significantly higher than controls (P = 0.0001, P < 0.003, P < 0.03 respectively). Soluble CD8 levels above the normal range (mean +/- 2 s.d. of controls) were found in a percentage of newly diagnosed subjects (54.5%) significantly higher than in subjects with a long-standing duration of disease (6.9%, P < 0.0005) and healthy siblings (16.2%, P < 0.002). Our results suggest that the raised levels of soluble CD8 near to diabetes onset may indicate the activation of CD8+ T cells probably responsible for the autoimmune beta cell destruction.
在1型(胰岛素依赖型)糖尿病(IDDM)中,CD8 + T细胞是在β细胞破坏过程中浸润胰岛的淋巴细胞的主要组成部分。可溶性CD8抗原(sCD8)已被证明与CD8细胞亚群的激活相关。在本研究中,我们通过ELISA法检测了以下人群血清中的sCD8水平:33例新诊断的IDDM患者;29例病程超过1年的1型糖尿病患者;37例IDDM患者的健康同胞;19名健康对照者。IDDM患者组和健康同胞的血清中可溶性CD8的平均水平均显著高于对照组(分别为P = 0.0001、P < 0.003、P < 0.03)。在一定比例的新诊断患者(54.5%)中发现可溶性CD8水平高于正常范围(对照组平均值±2标准差),这一比例显著高于病程较长的患者(6.9%,P < 0.0005)和健康同胞(16.2%,P < 0.002)。我们的结果表明,糖尿病发病时可溶性CD8水平升高可能表明CD8 + T细胞被激活,这可能是自身免疫性β细胞破坏的原因。